2023

1. Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients

   Haematologica, Vol. 108, Núm. 10, pp. 2753-2763